A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites; Oedema
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 08 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 Apr 2013 New trial record